Live Pain Free Post Chemo with Quell- the Wearable, App-Controlled Device that reduces symptoms of neuropathy

Managing side effects like chemotherapy-induced peripheral neuropathy (CIPN), can be challenging and painful. This condition affects up to 60% of people receiving neurotoxic chemotherapy and can significantly impact quality of life. But what if there was a simple, non-invasive way to potentially reduce CIPN symptoms? Enter the Quell device.

Developed in conjunction with the National Cancer Institute Community Oncology Research Program (NCORP), Quell is a wearable, app-controlled transcutaneous electrical nerve stimulation (TENS) device specifically designed for those with chronic CIPN. But what exactly does that mean?

Simply put, this device uses gentle electrical stimulation to target nerve fibers and potentially reduce pain and cramping in the affected area. But what sets Quell apart is its promising efficacy as shown in a randomized clinical trial, with an impressive 91% completion rate.

So how does it work? The device is worn on the affected area for just 60 minutes a day and can be controlled through a user-friendly app. This makes it a convenient and easy-to-use treatment option for those with busy lives.

But perhaps the most exciting aspect of Quell is its potential to improve overall function and quality of life for individuals with chronic CIPN. With daily symptom assessments, you can easily track your progress and see how Quell may be making a difference.

Don't just take our word for it, listen to the testimonials of others who have tried Quell and experienced relief from their CIPN symptoms. As always, consult with your doctor before trying any new treatment options.

In conclusion, if you're looking for a simple and effective way to potentially reduce pain and cramping associated with CIPN, give Quell Fibromyalgia a try.

QUELL